Biochemical aspects of schizophrenia.
D001327:Autoimmune Diseases / Q000150:complications; D001792:Blood Platelets / Q000201:enzymology; D001798:Blood Proteins / Q000378:metabolism; D002208:Caproates / Q000378:metabolism; D003402:Creatine Kinase / Q000378:metabolism; D004118:Dimethoxyphenylethylamine / Q000378:metabolism; D018492:Dopamine Antagonists; D006632:Histamine / Q000378:metabolism; D006651:Histocytochemistry; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism; D008661:Metabolism, Inborn Errors / Q000150:complications; D008995:Monoamine Oxidase / Q000097:blood; D010276:Parasympatholytics / Q000494:pharmacology; D012559:Schizophrenia / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism*; D013881:Thioridazine / Q000627:therapeutic use
D001798:Blood Proteins; D002208:Caproates; D004118:Dimethoxyphenylethylamine; D018492:Dopamine Antagonists; D008074:Lipoproteins; D010276:Parasympatholytics; D006632:Histamine; D008995:Monoamine Oxidase; D003402:Creatine Kinase; D013881:Thioridazine